Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cerebral Spinal Fluid Management Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Cerebral Spinal Fluid Management Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Cerebral Spinal Fluid Management Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Cerebral Spinal Fluid Management Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. CSF Shunts
4.3.1. CSF Shunts Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. CSF Drainage
4.4.1. CSF Drainage Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Cerebral Spinal Fluid Management Market: Valve Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Cerebral Spinal Fluid Management Market: Valve Movement Analysis, USD Million, 2023 & 2030
5.3. Adjustable Valve Shunts
5.3.1. Adjustable Valve Shunts Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Mono-pressure Valve Shunts
5.4.1. Mono-pressure Valve Shunts Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Cerebral Spinal Fluid Management Market: Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Cerebral Spinal Fluid Management Market: Type Movement Analysis, USD Million, 2023 & 2030
6.3. Ventriculoperitoneal (VP) Shunts
6.3.1. Ventriculoperitoneal (VP) Shunts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Ventriculoatrial (VA) Shunts
6.4.1. Ventriculoatrial (VA) Shunts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Lumboperitoneal (LP) Shunts
6.5.1. Lumboperitoneal (LP) Shunts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Ventriculopleural (VPL) Shunts
6.6.1. Ventriculopleural (VPL) Shunts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Cerebral Spinal Fluid Management Market: Age Group Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Cerebral Spinal Fluid Management Market: Age Group Movement Analysis, USD Million, 2023 & 2030
7.3. Adult
7.3.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Pediatric
7.4.1. Pediatric Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Cerebral Spinal Fluid Management Market: Regional Estimates & Trend Analysis
8.1. Cerebral Spinal Fluid Management Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
8.2.1. North America Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. China Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Japan Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. South Korea Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Australia Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Saudi Arabia
8.6.2.1. Saudi Arabia Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. UAE
8.6.3.1. UAE Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. South Africa
8.6.4.1. South Africa Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. B. Braun Melsungen AG
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Integra LifeSciences Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Spiegelberg GmbH & Co. KG
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Medtronic
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Sophysa
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Beckersmith Medical, Inc
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Natus Medical Inc.
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Elekta AB
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Phoenix Biomedical Corp.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives